title: Influenza vaccination responses in human systemic lupus erythematosus: impact of clinical and demographic features.
abstract: OBJECTIVE
  Vaccination against common pathogens, such as influenza, is recommended for patients with systemic lupus erythematosus (SLE) to decrease infections and improve health. However, most reports describing the vaccination response are limited to evaluations of SLE patients with quiescent disease. This study focuses on understanding the clinical, serologic, therapeutic, and demographic factors that influence the response to influenza vaccination in SLE patients with a broad range of disease activity.
  
  
  METHODS
  Blood specimens and information on disease activity were collected from 72 patients with SLE, at baseline and at 2, 6, and 12 weeks after influenza vaccination. Influenza-specific antibody responses were assessed by determining the total serum antibody concentration (B(max)), relative affinity (K(a)), and level of hemagglutination inhibition in the plasma. Using a cumulative score, the patients were evenly divided into groups of high or low vaccine responders. Autoantibody levels were evaluated at each time point using immunofluorescence tests and standard enzyme-linked immunosorbent assays.
  
  
  RESULTS
  Compared to high responders, low responders to the vaccine were more likely to have hematologic criteria (P = 0.009), to have more American College of Rheumatology classification criteria for SLE (P = 0.05), and to be receiving concurrent prednisone treatment (P = 0.04). Interestingly, European American patients were more likely to be low responders than were African American patients (P = 0.03). Following vaccination, low responders were more likely to experience disease flares (P = 0.01) and to have increased titers of antinuclear antibodies (P = 0.04). Serum interferon-α activity at baseline was significantly higher in patients in whom a flare occurred after vaccination compared to a matched group of patients who did not experience a disease flare (P = 0.04).
  
  
  CONCLUSIONS
  Ancestral background, prednisone treatment, hematologic criteria, and evidence of increased likelihood of disease flares were associated with low antibody responses to influenza vaccination in SLE patients.
authors: Oklahoma Medical Research Foundation, Oklahoma City, OK 73104, USA.
authors: Sherry R
authors: SR
authors: Crowe
authors: Joan T
authors: JT
authors: Merrill
authors: Evan S
authors: ES
authors: Vista
authors: Amy B
authors: AB
authors: Dedeke
authors: David M
authors: DM
authors: Thompson
authors: Scott
authors: S
authors: Stewart
authors: Joel M
authors: JM
authors: Guthridge
authors: Timothy B
authors: TB
authors: Niewold
authors: Beverly S
authors: BS
authors: Franek
authors: Gillian M
authors: GM
authors: Air
authors: Linda F
authors: LF
authors: Thompson
authors: Judith A
authors: JA
authors: James
references: Vaccine. 2005 Feb 3;23(11):1414-25
references: 15661391
references: Arthritis Rheum. 2009 Aug;60(8):2438-47
references: 19644961
references: J Immunol. 1993 Oct 1;151(7):3914-22
references: 8376810
references: Genes Immun. 2007 Sep;8(6):492-502
references: 17581626
references: Hum Immunol. 2000 Sep;61(9):845-9
references: 11053627
references: Best Pract Res Clin Rheumatol. 2002 Apr;16(2):281-91
references: 12041954
references: Ann N Y Acad Sci. 2005 Jun;1051:390-403
references: 16126981
references: Clin Dev Immunol. 2006 Jun-Dec;13(2-4):373-5
references: 17162380
references: Vaccine. 2006 Apr 12;24(16):3217-23
references: 16466833
references: Proc Natl Acad Sci U S A. 2003 Mar 4;100(5):2610-5
references: 12604793
references: Arthritis Rheum. 2007 Jul;56(7):2344-51
references: 17599763
references: Nature. 2008 May 29;453(7195):667-71
references: 18449194
references: Ann Intern Med. 1978 Jun;88(6):790-2
references: 307356
references: J Infect Dis. 2004 Dec 1;190(11):1962-9
references: 15529261
references: Arthritis Rheum. 1992 Jun;35(6):630-40
references: 1599520
references: N Engl J Med. 2005 Dec 15;353(24):2550-8
references: 16354891
references: Arthritis Rheum. 2004 Apr;50(4):1226-32
references: 15077305
references: Autoimmun Rev. 2007 Apr;6(5):300-5
references: 17412302
references: J Rheumatol. 2002 Dec;29(12):2555-7
references: 12465151
references: Medicine (Baltimore). 1999 May;78(3):167-75
references: 10352648
references: Arthritis Rheum. 2008 Jul;58(7):2113-9
references: 18576315
references: Immunol Today. 1999 Mar;20(3):119-24
references: 10203702
references: Nat Med. 2005 Jan;11(1):85-9
references: 15619631
references: Lupus. 2007;16(11):863-6
references: 17971358
references: Influenza Other Respir Viruses. 2007 Jul;1(4):147-56
references: 18458742
references: Rheumatology (Oxford). 2009 Oct;48(10):1294-9
references: 19692457
references: Clin Infect Dis. 2002 Jan 15;34(2):147-53
references: 11740700
references: Ann Intern Med. 1978 Jun;88(6):729-34
references: 352210
references: Autoimmun Rev. 2007 Sep;6(8):543-6
references: 17854746
references: Arthritis Rheum. 2005 May;52(5):1491-503
references: 15880830
references: Ann Rheum Dis. 2007 Nov;66 Suppl 3:iii61-4
references: 17934099
references: Autoimmun Rev. 2008 Dec;8(2):134-8
references: 18700173
references: N Engl J Med. 2003 Oct 16;349(16):1526-33
references: 14561795
references: Arthritis Rheum. 1982 Nov;25(11):1271-7
references: 7138600
references: Rev Invest Clin. 2004 Jan-Feb;56(1):16-20
references: 15144037
references: Ann Intern Med. 1978 Jun;88(6):735-40
references: 307353
references: JAMA. 2004 Sep 15;292(11):1333-40
references: 15367555
references: Arthritis Res Ther. 2006;8(2):R49
references: 16507174
references: Vaccine. 2009 Oct 23;27(45):6358-62
references: 19840673
references: Arthritis Rheum. 1998 Oct;41(10):1828-34
references: 9778224
references: Ann Rheum Dis. 2006 Jul;65(7):913-8
references: 16322083
references: Ann Intern Med. 1978 Jun;88(6):786-9
references: 666135
references: Arthritis Rheum. 2006 Jun;54(6):1906-16
references: 16736505
references: Vaccine. 2006 Mar 6;24(10):1609-14
references: 16260072
references: J Rheumatol. 2000 Jul;27(7):1681-5
references: 10914851
references: Lupus. 2001;10(3):152-3
references: 11315344
references: JAMA. 2003 Jan 8;289(2):179-86
references: 12517228
references: Clin Rheumatol. 2002 Sep;21(5):369-72
references: 12223983
references: Clin Exp Rheumatol. 1986 Apr-Jun;4(2):187-90
references: 3089659